$50 Million Investment in China Cord Blood Corp. by Shareholder of the Company

Represented China Cord Blood Corp. (NYSE: CO) in a $50 million private equity investment by Golden Meditech Holdings Ltd., a significant shareholder of the company. We provided counsel in connection with the issuance of convertible debt, the receipt of NYSE listing approval and related issues, and filings with the Securities and Exchange Commission.